Four notes on Zimmer Biomet’s first quarter financial results:
1. Zimmer Biomet’s net sales from continuing operations saw a 3.9 percent increase from the first quarter of 2021, the company said May 3.
2. The company saw $73 million in net earnings from continuing operations.
3. Diluted earnings per share from continuing operations for the company were $0.35.
4. Zimmer Biomet also completed the spinoff of ZimVie, its spine and dental business, in March.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
